Susquehanna International Group, LLP Regenxbio Inc. Transaction History
Susquehanna International Group, LLP
- $641 Billion
- Q4 2024
A detailed history of Susquehanna International Group, LLP transactions in Regenxbio Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 108,804 shares of RGNX stock, worth $909,601. This represents 0.0% of its overall portfolio holdings.
Number of Shares
108,804
Previous 55,387
96.44%
Holding current value
$909,601
Previous $581,000
44.75%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding RGNX
# of Institutions
191Shares Held
45.4MCall Options Held
184KPut Options Held
56.7K-
Black Rock Inc. New York, NY8.61MShares$72 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA4.79MShares$40.1 Million2.9% of portfolio
-
Jpmorgan Chase & CO New York, NY4.14MShares$34.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.99MShares$25 Million0.0% of portfolio
-
State Street Corp Boston, MA2.19MShares$18.3 Million0.0% of portfolio
About REGENXBIO Inc.
- Ticker RGNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,230,000
- Market Cap $361M
- Description
- REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...